Işık, Mehtap
Levorse, Dorothy
Rustenburg, Ariën S.
Ndukwe, Ikenna E.
Wang, Heather
Wang, Xiao
Reibarkh, Mikhail
Martin, Gary E.
Makarov, Alexey A.
Mobley, David L.
Rhodes, Timothy
Chodera, John D.
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
Article History
Received: 14 July 2018
Accepted: 26 September 2018
First Online: 7 November 2018
Compliance with ethical standards
:
: JDC was a member of the Scientific Advisory Board for Schrödinger, LLC during part of this study. JDC and DLM are current members of the Scientific Advisory Board of OpenEye Scientific Software. The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, the Molecular Sciences Software Institute, the Starr Cancer Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, and the Sloan Kettering Institute. A complete list of funding can be found at ExternalRef removed.